Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05486377
Other study ID # B-2205-757-001
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 2, 2022
Est. completion date May 19, 2023

Study information

Verified date August 2023
Source Seoul National University Bundang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In anesthesia for ablation for cardiac arrhythmias, abrupt hemodynamic changes or fatal arrhythmias can be seen frequently. Remimazolam is a novel ultra-short acting benzodiazepine that provides good hemodynamic stability compared to conventional anesthetic agents. This study aims to investigate whether remimazolam reduces vasoactive agent use during cryo/radiofrequancy ablation under general anesthesia, compared to desflurane(RCT).


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date May 19, 2023
Est. primary completion date May 19, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 105 Years
Eligibility Inclusion Criteria: - =or > 20 years - Admission for General anesthesia for RFCA or cryoablation procedure Exclusion Criteria: - No severe adverse effect history or hypersensitivity of benzodiazepines or its additives - Acute alcoholic intoxication state - Coma or shock state due to other condition than heart problem. - Acute narrow-angle glaucoma

Study Design


Intervention

Drug:
Remimazolam besylate
Remimazolam besylate TIVA

Locations

Country Name City State
Korea, Republic of Seoul national university Bundang hospital Seongnam Province (optional)

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vasopressor CIV Vasopressor CIV or not During anesthesia
Primary Hypotension event Hypotension event During and after anesthesia
Primary Vasopressor (total amount) Norepinephrine equivalent dose During anesthesia
Secondary Induction time Induction dose administration~LOC Induction
Secondary Recovery time Reversal agent administration~extubation Recovery
Secondary Adverse event Adverse event (desaturation, vomiting, hypotension, bleeding, allergic or anaphylaxis, etc.) During and after anesthesia (~24hr)
See also
  Status Clinical Trial Phase
Completed NCT04577430 - Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period N/A
Completed NCT03708692 - Menstrual Cycle Phases on Recovery and Cognitive Function
Recruiting NCT03422315 - Population Pharmacokinetics and Clinical Individual Dosage Regimen of Propofoll Injection N/A
Completed NCT02771067 - The Utility of Pulse Pressure Variation to Predict the Fluid Responsiveness During Pneumoperitoneum and Reverse-Trendelenburg Position N/A
Completed NCT05063461 - Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane N/A
Completed NCT03294226 - Comparison of AuraGain With I-gel for Pediatric Patients N/A
Not yet recruiting NCT03643029 - The Accuracy of the Performance and Placement Test for Predicting Supraglottic Airway Device (SAD) Position in the Hypopharynx as Confirmed With Video Laryngoscopy N/A
Completed NCT01945411 - Assessment of Facial Measurements, the Length of Mouth Corner-mandible Angle and Incisors-mandible Angle, for Determining the Proper Sizes of Oropharyngeal Airway N/A
Not yet recruiting NCT01678066 - A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor N/A
Completed NCT01705743 - Minimum Alveolar Concentration of Sevoflurane With Nitrous Oxide Inducing Isoelectric EEG Phase 4
Completed NCT00972491 - The Optimal Time to Put Laryngeal Mask Airway in the Mouth Under General Anesthesia N/A
Completed NCT00741507 - Unhealthy Alcohol Drinking and Anesthetic Requirement in Women N/A
Completed NCT01096212 - Efficacy and Safety of Sevofran in Patients Scheduled for Elective Surgery Under General Anesthesia Phase 4
Completed NCT00532402 - Continuous and Discontinuous Determination of Propofol Concentration in Breathing Gas N/A
Completed NCT00599066 - Intraoperative M-Entropy Measurements N/A
Completed NCT00468494 - Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia? N/A
Recruiting NCT00492453 - Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy N/A
Recruiting NCT03745079 - Correlation Between Core Temperature and Skin Temperature Measured by 3M SpotOn
Completed NCT04094376 - Comparison of Morning Operation and Evening Operation on Postoperative Sleep Quality and Pain Under General Anesthesia N/A
Enrolling by invitation NCT03672734 - Volume and pH of Gastric Contents in Patients Undergoing Gynecologic Laparoscopic Surgery During Emergence From General Anesthesia